BidaskClub cut shares of Surgery Partners, Inc. (NASDAQ:SGRY) from a sell rating to a strong sell rating in a research note published on Saturday, August 5th.
A number of other research analysts also recently issued reports on SGRY. Stifel Nicolaus cut their price target on Surgery Partners from $19.00 to $18.00 and set a hold rating on the stock in a report on Monday, April 24th. Zacks Investment Research downgraded Surgery Partners from a hold rating to a sell rating in a research note on Wednesday, May 10th. Three analysts have rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company. The stock presently has an average rating of Hold and an average target price of $20.67.
Shares of Surgery Partners (NASDAQ:SGRY) traded down 1.61% during mid-day trading on Friday, hitting $9.15. 214,282 shares of the stock traded hands. The stock has a market cap of $446.62 million, a price-to-earnings ratio of 60.20 and a beta of 1.71. Surgery Partners has a 52 week low of $8.95 and a 52 week high of $24.05. The firm’s 50-day moving average is $18.39 and its 200-day moving average is $19.89.
COPYRIGHT VIOLATION NOTICE: “Surgery Partners, Inc. (SGRY) Downgraded by BidaskClub” was originally published by BNB Daily and is owned by of BNB Daily. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.baseball-news-blog.com/2017/08/19/surgery-partners-inc-sgry-cut-to-strong-sell-at-bidaskclub-updated.html.
A number of hedge funds have recently modified their holdings of the company. Atria Investments LLC boosted its stake in shares of Surgery Partners by 2.3% in the second quarter. Atria Investments LLC now owns 10,627 shares of the company’s stock worth $242,000 after buying an additional 238 shares in the last quarter. Alliancebernstein L.P. boosted its stake in shares of Surgery Partners by 1.1% in the second quarter. Alliancebernstein L.P. now owns 28,400 shares of the company’s stock worth $646,000 after buying an additional 300 shares in the last quarter. Campbell Newman Asset Management Inc. boosted its stake in shares of Surgery Partners by 4.9% in the second quarter. Campbell Newman Asset Management Inc. now owns 12,649 shares of the company’s stock worth $288,000 after buying an additional 586 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in shares of Surgery Partners by 0.3% in the second quarter. Ameriprise Financial Inc. now owns 229,575 shares of the company’s stock worth $5,223,000 after buying an additional 605 shares in the last quarter. Finally, Parametric Portfolio Associates LLC boosted its stake in shares of Surgery Partners by 2.5% in the first quarter. Parametric Portfolio Associates LLC now owns 28,172 shares of the company’s stock worth $549,000 after buying an additional 689 shares in the last quarter. 38.42% of the stock is owned by institutional investors.
Surgery Partners Company Profile
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.